Yahoo Web Search

Search results

1. • 

     The Traitors’ Mollie Pearce: ‘I was told my colon could erupt at any moment’

     The Telegraph via Yahoo News· 4 days ago

     I’d had a vague idea of what ulcerative colitis was since I was little, as my dad had suffered from...

2. • Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive...

     Rome Sentinel· 6 days ago

     The data will be shared during the Digestive Disease Week® (DDW) 2024 Annual Meeting in Washington, D...

3. • 

     IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High

     Investor's Business Daily· 22 hours ago

     The company has submitted its applications for approval in the U.S. and Europe. Mirikizumab was as...

4. • ...Studies Show SonarMD Reduces Emergency Department Visits and Hospitalizations for Patients with...

     The Longview News-Journal· 2 days ago

     SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) – defined ...

5. • Eli Lilly Reports More than 50% Remission Rate in Crohn's Treatment Trial

     Morningstar· 1 day ago

     At one year, clinical remission was achieved by 54.1% of patients taking mirikizumab and endoscopic response, another important treatment target, was achieved by 48.4% of patients. The overall ...

6. • AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...

     The Longview News-Journal· 5 days ago

     - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)

7. • 

     The Traitors’ Mollie Pearce: ‘I was told my colon could erupt at any moment’

     Daily Telegraph· 4 days ago

     My parents of course took me to the doctor and, despite my mum explaining that my dad had ulcerative...

8. • New AI algorithm may improve autoimmune disease prediction and therapies

     Medical Xpress· 2 days ago

     The work, developed by a team led by Penn State College of Medicine researchers, outperforms existing methodologies and identified 26% more novel gene and trait associations ...

9. • Evotec Reports Q1 2024 Results and Provides Corporate Update

     Morningstar· 13 hours ago

     CHALLENGING Q1 WITH SOFTNESS MAINLY IN TRANSACTIONAL/DEVELOPMENT SHARED R&D BUSINESS AGAINST A STRONG COMPARABLE QUARTERSTRONG START WITH JUST - EVOTEC BIOLOGICS IN Q1 2024POSITIVE MOMENTUM ...

10. • Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at...

      Morningstar· 5 days ago

      LAVAL, QC / ACCESSWIRE / May 17, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that they will be presenting ...